BioCentury
ARTICLE | Clinical News

Bind Biosciences preclinical data

August 30, 2010 7:00 AM UTC

In a mouse model of solid tumors, BIND-014 delivered up to 20 times more docetaxel to the tumor site than an equivalent dose of Taxotere docetaxel from sanofi-aventis Group (Euronext:SAN; NYSE:SNY, ...